Introduction
Since juvenile hormone (JH) is involved in a wide range of physiological processes in insects such as metamorphosis, reproduction and diapause, 1) anti-JH agents, which chemically block the functioning of the JH control system, would be potentially useful not only as biochemical probes to assist in elucidating the role of JH in insect development and reproduction, but also as insect growth regulators. 2) We have recently found a novel anti-JH agent, ethyl 4-(2-benzylhexyloxy)benzoate (KF-13), 3) by modifying the structure of ethyl 4-[2-(tert-butylcarbonyloxy)-butyloxy]benzoate (ETB), which is the only compound reported to act as a partial JH antagonist in the larval epidermis of Manduca sexta in vitro. 4) ETB is also known to have both JH and anti-JH activities, depending on the doses applied. 5) KF-13 showed much stronger precocious metamorphosis-inducing (anti-JH) activity than ETB, but the JH activity of KF-13 was less than that of ETB. 6) KF-13 induced precocious metamorphosis at relatively low doses; however, at higher doses, its activity markedly decreased, probably due to the counteraction caused by KF-13 itself as a JH agonist. The anti-JH activity of KF-13 was completely counteracted by methoprene, a JH agonist, not by 20-hydroxyecdysone. 3) In our continuing studies of this series of compounds, we designed and synthesized indole derivatives 1, in which the chiral carbon portion of KF-13 is rigidified (Fig. 1) . In the present paper, we report anti-JH and JH activities of a novel series of ethyl 4-[(1-substituted indol-2-yl)methoxy]benzoates and related indoline derivatives.
Materials and Methods

Instrumental analysis and chemicals
1 H NMR spectra were determined with a JEOL EX-400 (400 MHz) spectrometer, using tetramethylsilane as an internal standard, and all samples were prepared in deuterochloroform. Methoprene (93.4%) was kindly supplied by Earth Biochemical Co. The preparation of a series of ethyl 4-[(1-substituted indol-2-yl)methoxy]benzoates and related (S)-indoline derivatives is outlined in Fig. 2 (A) and (B), respectively.
Methyl 1-ethylindole-2-carboxylate (II: RϭC 2 H 5 )
A solution of indole-2-carboxylic acid (1.0 g, 6.2 mmol) in 15 ml methanol containing a few drops of H 2 SO 4 was refluxed for 12 hr. After removing the solvent under reduced pressure, the residue was dissolved in ethyl acetate and the ethyl acetate solution was washed with 2M aq. NaOH solution and brine, and dried over Na 2 SO 4 . The concentration of the organic layer gave 1.06 g (97%) crude methyl indole-2-carboxylate.
To a solution of the above methyl indole-2-carboxylate (0.30 g, 1.7 mmol) in 5 ml DMSO was added potassium tert-butoxide (0.29 g, 2.6 mmol) and ethyl bromide (0.28 g, 2.6 mmol). After stirring for 16 hr at room temperature, the product was extracted with 100 ml ethyl acetate. The ethyl acetate solution was washed with brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by column chromatography on silica gel by eluting with hexane-ethyl acetate (9 : 1) to give 0.31 g (99%) of II (RϭC 2 H 5 ) as a colorless oil. 
Ethyl 4-[(1-ethylindol-2-yl)methoxy]benzoate (1a)
To a suspension of lithium aluminum hydride (0.04 g, 1.3 mmol) in 10 ml THF at 0°C was added II (RϭC 2 H 5 , 0.20 g, 1.0 mmol) and the mixture was stirred for 1 hr at room temperature. The reaction mixture was quenched with saturated NH 4 Cl solution and filtrated. After removing the solvent under reduced pressure, the residue was extracted with ethyl acetate. The ethyl acetate solution was washed with brine and dried over Na 2 SO 4 . The concentration of the organic layer gave 0.16 g (80%) crude 1-ethylindole-2-methanol.
To a solution of the above alcohol (0.20 g, 1.1 mmol) in 10 ml DMF was added triphenylphosphine (0.33 g, 1.3 mmol), ethyl 4-hydroxybenzoate (0.21 g, 1.3 mmol), and 40% diisopropyl azodicarbonate in toluene (0.63 g, 1.3 mmol). After stirring for 16 hr at room temperature, the product was extracted with ethyl acetate. The ethyl acetate solution was washed with 2 M aq. NaOH solution and brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by column chromatography on silica gel by eluting with hexane-ethyl acetate (6 : 1) to give 0.10 g (54%) of 1a as a colorless oil. 1 Compounds 1b-1d were prepared in the same manner as 1a using the corresponding alkyl bromide or iodide instead of ethyl bromide. 
Ethyl 4-[(1-n-propylindol-2-yl)methoxy]benzoate (1b)
(S)-1-(t-butyloxycarbonyl)indoline-2-methanol (IV)
Methyl (S)-indoline-2-carboxylate (III) was prepared from (S)-indoline-2-carboxylic acid in the same manner as methyl indole-2-carboxylate.
A solution of (III) (0.94 g, 5.3 mmol) and di-tert-butyl dicar- (1H, m, phenyl) .
Ethyl 4-[(S)-(1-n-butylindolin-2-yl)methoxy]benzoate (2a)
To a solution of (IV) (0.68 g, 2.7 mmol) in 15 ml CH 2 Cl 2 was added triethylamine (0.69 g, 6.8 mmol), p-toluenesulfonyl chloride (0.68 g, 3.6 mmol) and 4-dimethylaminopyridine (0.05 g). After stirring for 16 hr at room temperature, the solvent was removed under reduced pressure. The residue was dissolved in ethyl acetate and the ethyl acetate solution was washed with water and brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by column chromatography on silica gel by eluting with hexane-ethyl acetate (5 : 1) to give 1.01 g (92%) of (S)-(1-tert-butyloxycarbonylindolin-2-yl)methyl p-toluenesulfonate.
To a suspension of sodium hydride (0.09 g, 2.2 mmol) in 10 ml DMF at 0°C was added ethyl 4-hydroxybenzoate (0.37 g, 2.2 mmol). After stirring for 20 min at room temperature, the above p-toluenesulfonate (0.75 g, 1.9 mmol) was added to the mixture, which was heated for 6 hr at 80°C and then quenched with saturated NH 4 Cl solution. The product was extracted with ethyl acetate and the ethyl acetate solution was washed with water and brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by column chromatography on silica gel by eluting with hexane-ethyl acetate (10 : 1) to give 0.62 g (84%) ethyl 4 
-[(S)-(1-tert-butyloxycarbonylindolin-2-yl)methoxy]benzoate.
A solution of the above compound (0.62 g, 1.6 mmol) in 10 ml CH 2 Cl 2 containing 0.7 ml trifluoroacetic acid was stirred for 16 hr at room temperature. The product was extracted with ethyl acetate and the ethyl acetate solution was washed with saturated NaHCO 3 solution and brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by silica gel column chromatography by eluting with hexane-ethyl acetate (2 : 1) to give 0.45 g (97%) ethyl 4-[(S)-(indolin-2-yl)methoxy]benzoate as a pale yellow oil.
To a solution of the above compound (0.08 g, 0.2 mmol) in 10 ml DMF was added K 2 CO 3 (0.06 g, 0.4 mmol) and n-butyl bromide (0.2 g, 1.1 mmol). After stirring for 24 hr at room temperature, the product was extracted with ethyl acetate and the ethyl acetate solution was washed with brine, dried over Na 2 SO 4 , and concentrated. The residue was purified by column chromatography on silica gel by eluting with hexane-ethyl acetate (15 : 1) to give 0.05g (53%) of 2a as a pale yellow oil. 1 
Biological evaluation
B. mori (ShunreiϫShougetsu) larvae were reared on an artificial diet as previously reported.
7) The anti-JH activity of compounds was evaluated by the induction of precocious metamorphosis when topically applied to the dorsal abdomen of 24-hr-old 3rd instar larvae as previously described.
3) The JH activity of compounds was evaluated by molting into normal 5th instar when topically applied to allatectomized 4th instar larvae as previously described.
6)
Results and Discussion Table 1 shows precocious metamorphosis-inducing activity of indole and indoline derivatives against 3rd instar larvae of B. mori. 1-Ethylindole analog 1a had little activity. A marked increase in activity was observed by changing the ethyl to n-propyl group (1b). The activity of 1b at 1 mg was low in comparison with that Vol. 34, No. 3, 177-180 (2009) Anti-juvenile hormone activity of indole and indoline derivatives 179 of KF-13; however, at higher doses, 1b was more active than KF-13. Butyl (1c) and benzyl (1d) analogs showed almost the same level of activity as 1b. In contrast to KF-13, the activity of 1b, 1c and 1d did not decrease so much by increasing the applied doses. As previously reported, 3) the anti-JH activity of KF-13 at low dose levels was entirely due to the (S)-enantiomer. We therefore prepared (S)-1-butyl (2a) and (S)-1-benzyl (2b) indoline derivatives by starting with (S)-indoline-2-carboxylic acid. Both 2a and 2b showed lower activity than the corresponding indole derivatives, suggesting that the presence of a basic nitrogen atom is unfavorable for activity. KF-13 and its analogs have recently been found to exhibit JH activity as well as anti-JH activity; 6) therefore, we examined whether indole and indoline derivatives had JH activity using allatectomized 4th instar larvae of B. mori (Table 2 ). All allatectomized and acetone-treated control larvae underwent precocious metamorphosis. Methoprene prevented precocious metamorphosis at 1 mg so all treated larvae molted into 5th instar larvae. Indole analogs 1c and 1d had obvious JH activity at 40 mg each. It is noteworthy that in contrast to KF-13, 1c and 1d having JH activity clearly induced precocious metamorphosis even at high doses, suggesting that the JH activity of 1c and 1d was too weak to counteract their anti-JH activity. On the other hand, 1-butylindoline analog 2a showing precocious metamorphosis-inducing activity at high doses had no JH activity, while 1-benzylindoline analog 2b, which possessed less precocious metamorphosis-inducing activity than 2a, showed weak JH activity. Thus, a new series of 1-substituted indoles (1b, 1c and 1d), which are conformationally restricted analogs of KF-13, was found to show stronger precocious metamorphosis-inducing activity than KF-13 at high doses. Although these compounds also had JH activity, they might be a structurally novel class of leads for the development of anti-JH agents. a) Number of larvae tested: 10.
